Northern Trust Corp Cidara Therapeutics, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 160,356 shares of CDTX stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160,356

Previous 160,574 0.14%

Holding current value

$2.03 Million

Previous $126,000 16.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.64 - $0.92 $139 - $200	-218 Reduced 0.14%	160,356 $147,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $0.97 $22,174 - $31,630	32,609 Added 25.48%	160,574 $126,000
Q2 2023 Aug 11, 2023	BUY	$1.01 - $1.42 $16,184 - $22,754	16,024 Added 14.31%	127,965 $144,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $4,838 - $12,772	6,451 Added 6.12%	111,941 $142,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.81 $3,193 - $5,748	7,097 Added 7.21%	105,490 $66,000

Q1 2022 May 13, 2022	SELL	$0.67 - $1.39 $8,109 - $16,824	-12,104 Reduced 10.95%	98,393 $82,000
Q4 2021 Feb 08, 2022	BUY	$1.18 - $2.18 $48,114 - $88,889	40,775 Added 58.48%	110,497 $140,000
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.35 $4,004 - $6,359	-2,706 Reduced 3.74%	69,722 $156,000
Q2 2021 Aug 13, 2021	SELL	$1.87 - $2.7 $564,698 - $815,340	-301,978 Reduced 80.66%	72,428 $146,000
Q1 2021 May 12, 2021	SELL	$2.06 - $3.01 $32,160 - $46,992	-15,612 Reduced 4.0%	374,406 $996,000
Q4 2020 Feb 11, 2021	BUY	$1.99 - $3.25 $10,111 - $16,513	5,081 Added 1.32%	390,018 $780,000
Q3 2020 Nov 16, 2020	BUY	$2.85 - $4.1 $760,730 - $1.09 Million	266,923 Added 226.18%	384,937 $1.1 Million
Q2 2020 Aug 14, 2020	BUY	$2.39 - $4.0 $166,322 - $278,364	69,591 Added 143.71%	118,014 $436,000
Q1 2020 May 14, 2020	BUY	$1.74 - $4.26 $33,385 - $81,736	19,187 Added 65.63%	48,423 $120,000
Q4 2019 Feb 14, 2020	BUY	$1.77 - $3.84 $7,308 - $15,855	4,129 Added 16.45%	29,236 $112,000
Q3 2019 Nov 13, 2019	SELL	$1.25 - $2.35 $1,177 - $2,213	-942 Reduced 3.62%	25,107 $50,000
Q2 2019 Aug 13, 2019	SELL	$1.49 - $2.94 $5,326 - $10,510	-3,575 Reduced 12.07%	26,049 $44,000
Q1 2019 May 13, 2019	SELL	$2.35 - $3.27 $32,326 - $44,982	-13,756 Reduced 31.71%	29,624 $79,000
Q4 2018 Feb 12, 2019	BUY	$2.1 - $4.5 $543 - $1,165	259 Added 0.6%	43,380 $102,000
Q3 2018 Nov 14, 2018	BUY	$3.7 - $5.25 $21,219 - $30,108	5,735 Added 15.34%	43,121 $190,000
Q2 2018 Aug 14, 2018	BUY	$3.75 - $6.05 $6,768 - $10,920	1,805 Added 5.07%	37,386 $195,000
Q1 2018 May 09, 2018	BUY	$4.0 - $8.15 $72,056 - $146,814	18,014 Added 102.54%	35,581 $142,000
Q4 2017 Feb 14, 2018	SELL	$6.35 - $8.75 $3,638 - $5,013	-573 Reduced 3.16%	17,567 $119,000
Q3 2017 Nov 13, 2017	BUY	$5.75 - $8.1 $104,305 - $146,934	18,140	18,140 $147,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.1M

Call Options Held

2.7K

Put Options Held

100

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cidara Therapeutics, Inc. Transaction History